Key Takeaways
- Senior Vice President Arjun Kampani divested 88,000 RKLB shares on June 18 at $107.98 each, generating approximately $9.5 million in proceeds.
- Kampani’s holdings decreased by nearly 25% following the transaction; he maintains ownership of 264,705 shares valued at approximately $28.6 million.
- RKLB shares declined to $107.24 on exceptionally high trading activity — approaching triple the typical daily volume.
- The aerospace company delivered 63.4% revenue expansion compared to the prior year in Q1 and exceeded Wall Street projections.
- Rocket Lab will officially enter the Nasdaq-100 index on June 22, potentially attracting significant passive investment flows.
Rocket Lab’s (RKLB) Senior Vice President and General Counsel Arjun Kampani executed a significant stock sale on June 18, disposing of 88,000 shares at an average transaction price of $107.98. The sale generated approximately $9.5 million in total value.
After completing this transaction, Kampani retains direct ownership of 264,705 shares, currently worth around $28.6 million at recent market prices. The sale constitutes a 24.95% decrease in his overall position.
This recent divestiture follows a pattern of consistent selling activity. In late May, Kampani sold 28,668 shares at $142.57 on May 26, followed by 70,000 shares at $145.13 on May 27, and an additional 23,804 shares at $147.43 on May 28.
Throughout the trailing twelve months, Kampani has disposed of 342,714 shares in aggregate. Notably, company insiders have recorded zero share purchases during this timeframe, while 43 separate insider sales have been documented across the organization.
RKLB stock experienced a $0.74 decline, finishing the session at $107.24. Trading volume surged to 70.2 million shares — approximately three times the standard daily average of 24.8 million.
Shares Maintain Position Above Key Technical Levels
Notwithstanding recent weakness, RKLB continues trading substantially above its 200-day moving average of $82.68 and exceeds its 50-day moving average of $104.00. The stock has established a 52-week trading range between $27.84 and $151.00.
The company commands a market capitalization of $62.07 billion. Its price-to-earnings multiple registers at -335.12, indicating the firm remains unprofitable. With a beta coefficient of 2.49, the stock demonstrates considerably higher volatility than the overall market.
Wall Street analysts maintain an average price objective of $102.76 alongside a “Moderate Buy” consensus recommendation. Individual targets span from $105 (KGI Securities, neutral stance) to $150 (New Street Research, buy rating). Stifel Nicolaus established a $132 target; KeyCorp recently elevated its rating to overweight with a $135 price objective.
Operational Performance Strong Despite Valuation Concerns
During its latest quarterly disclosure on May 7, Rocket Lab reported revenue of $200.35 million, surpassing analyst consensus estimates of $189.65 million by roughly $10.7 million.
Top-line growth registered 63.4% compared to the year-ago period. Adjusted earnings per share reached -$0.07, aligning with expectations. The company maintains a robust $2.2 billion order backlog.
Rocket Lab also successfully completed a critical Space Development Agency technical review, bolstering its position in defense contracting.
Commencing June 22, RKLB will officially join the Nasdaq-100 index composition. This inclusion generally catalyzes automated purchasing from index-tracking funds and exchange-traded products.
Institutional investors currently control 71.78% of outstanding shares. Vanguard manages 47.4 million shares, Baillie Gifford possesses 17.9 million, and Capital World Investors maintains 16.2 million.
GuruFocus calculates an intrinsic value estimate of $26.42 per share, resulting in a price-to-GF-Value multiple of 4.09 — a metric the platform characterizes as significantly overvalued.
Sell-side forecasters project full-year adjusted EPS of -$0.29 for the ongoing fiscal period.


